Trial Profile
A study investigating the effect of Pneumococcal-13-valent-CRM197-vaccine-conjugate in chronic lymphocytic Leukaemia patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Dec 2015
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 23 Dec 2015 New trial record